Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 1,798.00
-6.00 (-0.33%)
At close: Jul 28, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 139.8 billion as of July 28, 2026. Its market cap has decreased by -53.78% in one year.
Market Cap
139.80B
Enterprise Value
224.23B
Revenue
18.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,798.00
ChartMarket Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 139.80B, a decrease of -77.20%. That is a compound annual growth rate of -24.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 139.80B | -40.76% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| curacle co.,ltd. | 191.31B |
| Genome & Company | 168.80B |
| NIBEC | 161.76B |
| Ensol Biosciences | 161.33B |
| Kanaph Therapeutics | 160.52B |
| Bio Solution | 158.70B |
| ISU Abxis | 150.26B |
| Y-Biologics | 143.37B |